- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT07727837
The Relationship Between Pelvic Floor Dysfunction and Quality of Life, Functional Capacity, Gait Parameters, and Static Balance in Children With Defecation Disorders
Defecation disorders are common in children and may adversely affect pelvic floor function, gait, balance, functional capacity, and health-related quality of life. Although pelvic floor dysfunction is considered an important component of defecation disorders, its relationship with gait characteristics, plantar pressure distribution, static balance, functional capacity, and health-related quality of life has not been fully investigated in children.
The aim of this study is to investigate the relationship between pelvic floor function and gait parameters, plantar pressure distribution, static balance, functional capacity, and health-related quality of life in children with defecation disorders. Pelvic floor function will be evaluated using surface electromyography and the Kelly Continence Score. Gait parameters, plantar pressure distribution, static balance, functional capacity, and health-related quality of life will be assessed using validated and standardized assessment methods.
Přehled studie
Postavení
Podmínky
Detailní popis
Defecation disorders are among the most common gastrointestinal disorders in children and are associated with impaired pelvic floor function, reduced functional capacity, altered gait characteristics, balance impairments, and decreased health-related quality of life. Despite the recognized role of pelvic floor dysfunction in children with defecation disorders, the relationship between pelvic floor function and physical performance outcomes has not been comprehensively investigated.
This observational study aims to evaluate the relationship between pelvic floor function and gait parameters, plantar pressure distribution, static balance, functional capacity, and health-related quality of life in children with defecation disorders.
Eligible participants will undergo a comprehensive baseline assessment. Demographic and clinical characteristics, including age, sex, anthropometric measurements, medical history, and defecation characteristics, will be recorded. Defecation disorders will be evaluated according to the Rome IV diagnostic criteria.
Pelvic floor function will be assessed using surface electromyography and the Kelly Continence Score. Functional capacity, gait parameters, plantar pressure distribution, static balance, and health-related quality of life will be evaluated using validated assessment methods. The relationships between pelvic floor function and the clinical and functional outcome measures will be analyzed.
Typ studie
Zápis (Odhadovaný)
Kontakty a umístění
Studijní kontakt
- Jméno: Ayşe KAYALI VATANSEVER, Asst. Prof. Dr.
- Telefonní číslo: +905529382360
- E-mail: ayse.vatansever@bakircay.edu.tr
Studijní místa
-
-
-
Izmir, Turecko (Türkiye)
- Nábor
- Ege University Faculty of Medicine, Department of Pediatric Surgery
-
Kontakt:
- Ayşe KAYALI VATANSEVER, Asst. Prof. Dr.
- Telefonní číslo: +905529382360
- E-mail: ayse.vatansever@bakircay.edu.tr
-
Kontakt:
- Dilek Bayraktar, Asst. Prof. Dr.
- Telefonní číslo: +905377265535
- E-mail: dilekbayraktar8@gmail.com
-
-
Bornova
-
Izmir, Bornova, Turecko (Türkiye), 35100
- Zatím nenabíráme
- Ege university
-
Kontakt:
- Dilek BAYRAKTAR, Dr. PT
- Telefonní číslo: +905377265535
- E-mail: dilekbayraktar8@gmail.com
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dítě
- Dospělý
Přijímá zdravé dobrovolníky
Metoda odběru vzorků
Studijní populace
Popis
Inclusion Criteria:
- Being between 6 and 18 years of age
- Diagnosed with a defecation disorder by a pediatric surgeon according to Rome IV clinical criteria
- Having a history of constipation or fecal incontinence lasting at least 3 months
- Cognitive and auditory abilities sufficient to understand and follow simple verbal commands
- Written consent provided by the child's parent or legal guardian
Exclusion Criteria:
- Having orthopedic or neurological conditions that would impair lower extremity movements or walking
- History of surgery within the last 6 months
- History of neurological disorders (e.g., cerebral palsy, epilepsy, neuromuscular diseases)
- Having visual or hearing impairments severe enough to prevent participation in the study
Studijní plán
Jak je studie koncipována?
Detaily designu
Kohorty a intervence
Skupina / kohorta |
|---|
|
Children with Defecation Disorders
Children aged 6-18 years diagnosed with defecation disorders according to the Rome IV criteria.
Participants will undergo assessments of pelvic floor function, continence status, gait parameters, plantar pressure distribution, static balance, functional capacity, and health-related quality of life.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Resting Pelvic Floor Muscle Activity (µV)
Časové okno: Baseline (at study entry)
|
Resting pelvic floor muscle activity will be quantified using the MyOnyx surface electromyography (sEMG) system.
Average onset time and work mean values during the resting phase will be recorded.
|
Baseline (at study entry)
|
|
Pelvic Floor Muscle Maximum Voluntary Contraction (µV)
Časové okno: Baseline (at study entry)
|
Pelvic floor muscle activity during maximum voluntary contraction will be quantified using the MyOnyx surface electromyography (sEMG) system.
Average onset time and work mean values during maximum voluntary contraction will be recorded.
|
Baseline (at study entry)
|
|
Pelvic Floor Muscle Activity During Straining (µV)
Časové okno: Baseline (at study entry)
|
Pelvic floor muscle activity during straining will be quantified using the MyOnyx surface electromyography (sEMG) system.
Average onset time and work mean values during straining will be recorded.
|
Baseline (at study entry)
|
|
Pediatric Quality of Life Inventory (PedsQL™ 4.0) Child Self-Report Total Score
Časové okno: Baseline (at study entry)
|
Health-related quality of life will be assessed using the Pediatric Quality of Life Inventory (PedsQL™ 4.0) child self-report form.
The total score will be calculated and reported.
|
Baseline (at study entry)
|
|
Pediatric Quality of Life Inventory (PedsQL™ 4.0) Parent Proxy-Report Total Score
Časové okno: Baseline (at study entry)
|
Health-related quality of life will be assessed using the Pediatric Quality of Life Inventory (PedsQL™ 4.0) parent proxy-report form.
The total score will be calculated and reported.
|
Baseline (at study entry)
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Functional Capacity
Časové okno: Baseline (at study entry)
|
Functional capacity will be assessed using the Six-Minute Walk Test (6MWT).
The total distance walked in six minutes (meters) will be recorded.
|
Baseline (at study entry)
|
|
Anal Continence (Kelly Continence Score)
Časové okno: Baseline (at study entry)
|
Continence status will be assessed using the Kelly Continence Score.
|
Baseline (at study entry)
|
|
Walking Speed (km/h)
Časové okno: Baseline (at study entry)
|
Walking speed will be assessed using the Materialise Motion Footscan® v9 Scientific.
|
Baseline (at study entry)
|
|
Cadence (steps/min)
Časové okno: Baseline (at study entry)
|
Cadence will be assessed using the Materialise Motion Footscan® v9 Scientific.
|
Baseline (at study entry)
|
|
Step Length (cm)
Časové okno: Baseline (at study entry)
|
Step length will be assessed using the Materialise Motion Footscan® v9 Scientific.
|
Baseline (at study entry)
|
|
Subtalar Joint Flexion (degrees)
Časové okno: Baseline (at study entry)
|
Subtalar joint flexion will be assessed using the Materialise Motion Footscan® v9 Scientific.
|
Baseline (at study entry)
|
|
Foot Type Classification
Časové okno: Baseline (at study entry)
|
Foot type will be classified as pes planus, pes cavus, or neutral using the Materialise Motion Footscan® v9 Scientific.
|
Baseline (at study entry)
|
|
Center of Pressure Path Length (mm)
Časové okno: Baseline (at study entry)
|
Static balance will be assessed using the Materialise Motion Footscan® v9 Scientific.
Center of pressure (COP) path length will be recorded.
|
Baseline (at study entry)
|
|
Mean Center of Pressure Velocity (mm/s)
Časové okno: Baseline (at study entry)
|
Static balance will be assessed using the Materialise Motion Footscan® v9 Scientific.
Mean center of pressure (COP) velocity will be recorded.
|
Baseline (at study entry)
|
|
Static Plantar Pressure Distribution
Časové okno: Baseline (at study entry)
|
Static plantar pressure distribution will be assessed using the Materialise Motion Footscan® v9 Scientific.
Pressure distribution in the forefoot, midfoot, and rearfoot regions of both feet will be recorded.
|
Baseline (at study entry)
|
Spolupracovníci a vyšetřovatelé
Sponzor
Spolupracovníci
Vyšetřovatelé
- Vrchní vyšetřovatel: Ayşe KAYALI VATANSEVER, Asst. Prof. Dr., Bakırçay University
- Ředitel studie: Dilek BAYRAKTAR, Dr. PT, Ege university
- Ředitel studie: Ahmet ÇELİK, Prof. Dr., Ege university
- Ředitel studie: Mustafa Orkan ERGÜN, Prof. Dr., Ege university
- Ředitel studie: Sena ÖZDEMİR, Bakırçay University
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další identifikační čísla studie
- 2728
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .